PharmiWeb.com - Global Pharma News & Resources

Company Directory - Pharmaco

Pfizer is one of the world's premier innovative biopharmaceutical companies, discovering, developing and providing over 170 different medicines and vaccines healthcare products to help improve the lives of millions of people around the world.
Phetairos are a community of world class subject matter experts and consultants with wide experience of functional and leadership positions within BioPharma/Life science: With this aggregated experience of 5000 years! – which is truly unique in the industry – we can help you release the full potential of your products, organisation and people.
Pierre Fabre is the 2nd largest dermo-cosmetics laboratory in the world, the 2nd largest private French pharmaceutical group and the market leader in France for products sold over the counter in pharmacies.
With approximately 400 staff in a wide range of roles from those working in our pharmaceutical manufacturing plants, through to our quality and scientific development groups, we focus on developing and manufacturing life-saving products.
Our research and development is focused on areas of unmet medical need in major therapeutic areas of oncology, wound healing, inflammatory diseases and infectious diseases. We develop our products simultaneously for the human and veterinary markets.
Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Relief is a biopharmaceutical company whose objective is to provide patients with therapeutic RELIEF in serious diseases with high unmet medical need. We focus on clinical-stage programs based on molecules with a history of clinical use (well-established safety and tolerability) and either initial human activity or efficacy data (proof of concept) or a strong scientific rationale.
Richmond Pharmacology is one of Europe’s leading early phase Contract Research Organizations, focusing on phase 1, first in human studies, TQT studies and bridging studies, with a growing phase 2 and phase 3 portfolio too.
Riemser Pharma GmbH ( www.riemser.com ) is part of the global pharmaceutical company ESTEVE ( www.esteve.com ) based in Barcelona. Riemser was founded in 1992 and buys, licenses, markets and sells pharmaceutical products.
We help millions of people all over the world live longer and better lives every hour of every day and we’ve been writing scientific history for over 120 years, striving to solve some of the greatest, most complex health challenges facing humanity.
Roma Pharma, a leading third-party injection manufacturer, boasts over 40 years of industry expertise. With a strong commitment to quality and safety, the company is GMP certified, ensuring all manufacturing processes meet the highest standards.
SAB Biotherapeutics, Inc. (SAB) is a clinical-stage, biopharmaceutical company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies.
Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people’s lives.
As a specialized pharmaceutical company, Santen continues to make utmost efforts to contribute to ophthalmic treatment around the world.
We are focusing on the development of treatments for neuromuscular and pulmonary diseases that currently lack treatment options, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF). We have dedicated more than a decade to researching potential treatments in our ongoing mission to make effective medicines available for these often overlooked, life-altering diseases.
Servier is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes). With a strong international presence in 149 countries and a turnover of 4.2 billion euros in 2018, Servier employs 22,000 people worldwide.
Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again.
Shionogi B.V. (known as “Shionogi Europe”) is the European headquarters of Shionogi & Co., Ltd, a leading global research-driven pharmaceutical company based in Osaka, Japan. Since 1878, we have been striving to supply the best possible medicines to protect the health and wellbeing of the patients we serve.
Established 1921 in Switzerland, Sintetica is a pharmaceutical company delivering injectable anaesthetics and analgesics to patients worldwide, through innovative science and excellence in development, production and marketing. Our sites are located in Switzerland Germany, Austria and United Kingdom.